InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,277.51
(
0.80%
)
US TECH 100
18,064.80
(
0.02%
)
Dow Jones
38,686.32
(
1.51%
)
Brent Oil
81.30
(
0.00%
)
Bitcoin
67,650.62
(
0.25%
)
Post# of 30990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

knuts4oe

Send PM Follow Ignore
Followers 4
Posts 682
Boards Moderated 0
Alias Born 06/26/2013

knuts4oe

Re: mdropp post# 28419

Saturday, 07/29/2017 9:52:02 PM

Saturday, July 29, 2017 9:52:02 PM

Post# of 30990
That's correct, mdropp. Nilvadipine is a 20+ year old blood pressure medication. Roskamp has invested a great deal of time, effort, and money to investigate the medical potential of both Nilvad and Anatabine, and is very unlikely to walk away from either, especially since both represent a near monopoly on their effectiveness.

That could include a combined Nilvad/Anatabine to treat Alzheimer's, although I have never heard of any attempt to test such a combination.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up